Metraipolis › archive › dc_048bb952d548

Claudins in ovarian cancer: emerging biomarkers and therapeutic targets — Europe PMC PMID:40802677

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40802677
DOI: 10.1080/21688370.2025.2539026
License (as archived): solo-consultazione
Archived: 2026-11-10T16:17:17.837Z
SHA-256 of the archived text: 87f29ee4449f5a149567e696cc49d137a39ad590b22b379404ad4e6ed6f37d29
Stable URL of this page: https://metraipolis.com/documento/dc_048bb952d548

How to cite

Claudins in ovarian cancer: emerging biomarkers and therapeutic targets — Europe PMC PMID:40802677 — Europe PMC (en), https://europepmc.org/article/MED/40802677 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_048bb952d548 (Metraipolis archive dc_048bb952d548, sha256 87f29ee4449f5a149567e696cc49d137a39ad590b22b379404ad4e6ed6f37d29)

BibTeX

@misc{dc048bb952d548,
  title = {Claudins in ovarian cancer: emerging biomarkers and therapeutic targets — Europe PMC PMID:40802677},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40802677},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_048bb952d548; sha256 87f29ee4449f5a149567e696cc49d137a39ad590b22b379404ad4e6ed6f37d29},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40802677. Agents can read the archived copy with the MCP tool read_document.